Back to search

Peptide record

TPDB24434

Antibacterial Anticancer Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB24434
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 20-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
QIFKKVKTWYKKAFQILGRL
Physicochemical Analysis
C122H195N31O25
NDCEHMPS
K
2496.08
11.14
6
0
10
+6
0.18
-0.305
97.50
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
6990
280.04
4
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
0
E
2
Q
1
G
0
H
2
I
2
L
5
K
0
M
2
F
0
P
0
S
1
T
1
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 1 H: 0 I: 2 L: 2 K: 5 M: 0 F: 2 P: 0 S: 0 T: 1 W: 1 Y: 1 V: 1
Chemical Descriptors
20
C122H195N31O25
2496.08
11.14
+6
0.18
-0.305
Evidence Records 3 records
Evidence 1 Activity

Activity

EC50
Toxicity
21±2 µM
Cytotoxic
EC50 | 21±2 | µM | target cell: Human dermal microvascular endothelial cells HDME

Target

Human dermal microvascular endothelial cells HDME

Source & Reference

NA
DBAASP
In silico design and optimization of selective membranolytic anticancer peptides. | Sci Rep | 2019
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
In silico design and optimization of selective membranolytic anticancer peptides. | Sci Rep | 2019
Evidence 3 Activity

Activity

HC50
Toxicity
100 µM
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: HC50>100 µM | Cytotoxicity: HDMEC: EC50=21 ± 2 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Sci Rep. 2019 Aug 2 9(1):11282.